Home > Press > New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control
![]() |
Temperature response of the peptide. It forms solid (gel) at 20 degree Celsius and liquid (sol) at 80 degree Celsius indicated by white brackets, and this feature is reversible.
CREDIT Takahiro Muraoka, TUAT |
Abstract:
A collaboration mainly led by scientists from Tokyo University of Agriculture and Technology (TUAT) in Japan has developed a new method of molecular design to control both temperature reversibility and stiffness of nanofibers that are gel-forming peptides. The peptide nanofiber hydrogel can be used as biomedical materials. This method will allow the peptide nanofibers more biomedical applicable.
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control
Tokyo, Japan | Posted on September 30th, 2019
The researchers published their results on July 8th in Chemistry-A European Journal, which was highlighted in the Front Cover and Cover Profile.
In general, some of peptides form nanofiber hydrogels. These peptides are short chains of natural amino acids found in all living organisms. Since these are bio-friendly, these have been widely used in medicine such as tissue recovery materials, regenerative medical materials, extracellular matrices, cell culture materials, and drug delivery containers.
“For some medical applications of nanofiber peptides, we need to develop a technique to control both stiffness (mechanical strength) and temperature response changing between gel (solid) and sol (liquid),” said Takahiro Muraoka, PhD, corresponding author on the paper and associate professor in the Department of Applied Chemistry, Graduate School of Engineering at TUAT. “It is, however, difficult to make better the both features at the same time. For example, when increasing stiffness of a peptide nanofiber by replacement of a simple amino acid alanine to a more hydrophobic amino acid phenylalanine, it is known that temperature response is often lost.”
In their experiments, they found that an amino acid replacement that was thought to make a softer gel unexpectedly formed a harder gel. They used 5 sets of different peptides that had 16 amino acids. Interestingly, one particular peptide did not lose temperature response. The peptide (concentration at 1% in solution) formed gel (solid) at 20°C (68°F) and when increasing temperature to 80°C (178°F) the gel became sol (liquid). When reducing temperature from 80°C to 20°C, gel was again formed. “This temperature reversible feature is applicable for drug delivery by local injection,” said Muraoka.
They replaced alanine in the middle of the peptide to glycine, the simplest amino acid. The glycine replacement usually makes the gel softer. They used regular analytical instrument such as CD, IR, and TEM microscopy to understand precisely how the gel was formed. They also used a computational approach, called molecular dynamics simulation. “Based on our results, we are now able to design peptides better by computer simulation,” said Muraoka.
Furthermore, the peptide nanofiber was cell adhesive, which is suitable as a biomaterial for cell culture and tissue regeneration. “This research will open new avenues towards designing peptide nanofibers more biomedical applicable,” Muraoka added.
####
About Tokyo University of Agriculture and Technology
TUAT is a distinguished university in Japan dedicated to science and technology. TUAT focuses on agriculture and engineering that form the foundation of industry, and promotes education and research fields that incorporate them. Boasting a history of over 140 years since our founding in 1874, TUAT continues to boldly take on new challenges and steadily promote fields. With high ethics, TUAT fulfills social responsibility in the capacity of transmitting science and technology information towards the construction of a sustainable society where both human beings and nature can thrive in a symbiotic relationship.
For more information, please click here
Contacts:
Yutaka Nibu, Ph.D.
81-423-887-550
Takahiro Muraoka, PhD.
Associate Professor
Department of Applied Chemistry, Graduate School of Engineering, TUAT, Japan.
Copyright © Tokyo University of Agriculture and Technology
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
For more information about the Muraoka laboratory, please visit:
News and information
Neuroprosthetic and Exoskeleton Allow Tetraplegic Patient to Move October 7th, 2019
Product authentication at your fingertips: UC Riverside-led research brings rapid and reversible switching of plasmonic color to solids October 4th, 2019
Nanoparticles Inside Samples of Mucus to Measure COPD Development October 4th, 2019
Oxford Instruments Supplies HLJ Technology Co. Ltd., with Plasma Etch and Deposition Solutions for the fabrication of VCSELS on 6 inch wafers October 3rd, 2019
Possible Futures
Neuroprosthetic and Exoskeleton Allow Tetraplegic Patient to Move October 7th, 2019
Product authentication at your fingertips: UC Riverside-led research brings rapid and reversible switching of plasmonic color to solids October 4th, 2019
Nanoparticles Inside Samples of Mucus to Measure COPD Development October 4th, 2019
Researchers synthesize ‘impossible’ superconductor October 3rd, 2019
Nanomedicine
Nanoparticles Inside Samples of Mucus to Measure COPD Development October 4th, 2019
New materials to help stop lithium-ion battery fires, explosions and improve battery performance October 2nd, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences October 1st, 2019
Probes shed new light on Alzheimer’s cause: Rice University scientists synthesize fluorescent ruthenium tags to track toxic amyloids in lab September 27th, 2019
Discoveries
Product authentication at your fingertips: UC Riverside-led research brings rapid and reversible switching of plasmonic color to solids October 4th, 2019
Nanoparticles Inside Samples of Mucus to Measure COPD Development October 4th, 2019
Researchers synthesize ‘impossible’ superconductor October 3rd, 2019
Researchers repurpose failed cancer drug into printable semiconductor October 3rd, 2019
Announcements
Neuroprosthetic and Exoskeleton Allow Tetraplegic Patient to Move October 7th, 2019
Product authentication at your fingertips: UC Riverside-led research brings rapid and reversible switching of plasmonic color to solids October 4th, 2019
Nanoparticles Inside Samples of Mucus to Measure COPD Development October 4th, 2019
Oxford Instruments Supplies HLJ Technology Co. Ltd., with Plasma Etch and Deposition Solutions for the fabrication of VCSELS on 6 inch wafers October 3rd, 2019
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Product authentication at your fingertips: UC Riverside-led research brings rapid and reversible switching of plasmonic color to solids October 4th, 2019
Nanoparticles Inside Samples of Mucus to Measure COPD Development October 4th, 2019
Researchers synthesize ‘impossible’ superconductor October 3rd, 2019
Researchers repurpose failed cancer drug into printable semiconductor October 3rd, 2019
Nanobiotechnology
Nanoparticles Inside Samples of Mucus to Measure COPD Development October 4th, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences October 1st, 2019
Novel nanogels hold promise for improved drug delivery to cancer patients: ‘Precision Medicine’ approach underpins UT Austin engineers’ development of multifunctional nanogel September 27th, 2019
Probes shed new light on Alzheimer’s cause: Rice University scientists synthesize fluorescent ruthenium tags to track toxic amyloids in lab September 27th, 2019